FDA Issues Guidance on GDUFA II Fee Payments and Consequences

Generic Line
The FDA published a draft guidance explaining the new GDUFA fee structure and the types of fees that took effect Oct. 1. The draft also covers how to submit payments to the agency, the consequences for failing to pay, and how to request reconsiderations of user fee assessments.

To View This Article:


Subscribe To Generic Line